Metagenomi Therapeutics Balance Sheet (2023-2026) | MGX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter) 6.43M11.27M15.96M
Receivables - Accured (Quarter) 1.00M1.30M1.40M1.60M1.60M1.60M1.40M1.30M1.20M1.00M
Assets
Current Assets
Cash & Equivalents (Quarter) 95.67M51.65M101.90M140.60M102.56M61.18M25.12M27.39M29.20M26.85M32.77M41.72M25.31M
Receivables - Net (Quarter) 2.00M2.08M1.65M0.10M1.10M0.90M0.90M0.30M
Receivables (Quarter) 2.00M2.08M1.65M0.10M1.10M0.90M0.90M0.30M
Prepaid Assets (Quarter) 4.64M6.16M6.01M7.12M8.40M6.21M5.82M4.75M4.43M4.40M
Current Assets (Quarter) 278.27M335.64M307.58M282.29M257.96M233.19M211.68M189.82M165.54M144.56M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 21.54M20.96M20.71M19.72M17.74M16.52M15.11M13.89M12.29M11.16M
Long-Term Investments (Quarter) 5.65M8.52M8.52M8.52M8.52M10.58M3.45M1.29M2.15M2.15M2.15M
Other Non-Current Assets (Quarter) 6.07M5.25M5.25M5.25M5.25M5.25M5.25M5.25M5.25M5.25M5.25M0.84M4.39M
Non-Current Assets (Quarter) 86.57M79.76M78.33M76.06M66.64M64.67M60.60M58.12M55.56M52.40M
Assets (Quarter) 364.84M415.40M385.90M358.35M324.60M297.87M272.28M247.94M221.10M196.95M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.79M6.84M3.45M3.10M0.53M2.67M2.89M1.22M1.49M2.40M
Payables (Quarter) 1.79M6.84M3.45M3.10M0.53M2.67M2.89M1.22M1.49M2.40M
Accumulated Expenses (Quarter) 11.47M7.08M10.98M8.84M8.42M6.12M5.92M9.90M6.72M1.29M
Other Accumulated Expenses (Quarter) 0.45M0.12M0.28M0.31M0.17M0.23M
Current Leases (Quarter) 3.43M4.38M5.40M4.70M5.59M5.60M5.51M5.57M6.03M6.11M
Current Taxes (Quarter) 3.27M3.27M
Current Deferred Revenue (Quarter) 48.07M48.29M32.98M29.05M22.76M25.50M18.94M12.90M8.70M9.31M
Total Current Liabilities (Quarter) 68.86M70.70M52.81M45.69M37.31M39.89M33.27M29.58M22.93M22.50M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 30.93M20.31M17.33M12.43M10.24M4.37M3.55M1.90M2.99M1.64M
Preferred Stock Liabilities (Quarter) 350.76M350.76M350.76M350.76M
Operating Leases (Quarter) 44.80M43.68M42.55M41.38M40.19M38.83M37.48M36.09M34.63M33.08M
Other Non-Current Liabilities (Quarter) 5.08M5.08M3.80M3.08M2.01M2.11M2.15M1.92M1.95M1.95M
Total Non-Current Liabilities (Quarter) 144.59M134.69M112.68M99.50M87.73M83.10M74.30M67.57M60.55M57.22M
Total Liabilities (Quarter) 90.01M102.54M0.12M149.67M139.77M116.49M102.58M89.74M85.21M76.45M69.49M62.51M59.17M
Shareholder's Equity
Common Equity (Quarter) -90.01M-102.54M-0.12M-135.58M275.63M269.42M255.77M234.86M212.66M195.83M178.45M158.60M137.78M
Shareholder's Equity (Quarter) -90.01M-102.54M-0.12M-135.58M275.63M269.42M255.77M234.86M212.66M195.83M178.45M158.60M137.78M
Liabilities and Shareholders Equity (Quarter) 364.84M415.40M385.90M358.35M324.60M297.87M272.28M247.94M221.10M196.95M
Retained Earnings (Quarter) -144.94M-170.09M-180.83M-199.60M-223.00M0.62M0.37M-288.34M0.26M-0.04M
Treasury Shares (Quarter) 0.92M0.77M0.59M0.46M0.43M0.68M0.59M0.06M0.04M
Shares Outstanding (Quarter) 3.40M3.40M3.40M3.40M37.47M37.46M37.43M37.42M37.38M37.53M37.55M37.62M37.65M